Literature DB >> 26395512

Versican localizes to the nucleus in proliferating mesenchymal cells.

Jon M Carthy1, Thomas Abraham1, Anna J Meredith1, Seti Boroomand1, Bruce M McManus2.   

Abstract

OBJECTIVE: Versican is a versatile and highly interactive chondroitin sulfate proteoglycan that is found in the extracellular matrix (ECM) of many tissues and is a major component of developing and developed lesions in atherosclerotic vascular disease. In this paper, we present data to indicate that versican may have important intracellular functions in addition to its better known roles in the ECM. METHODS AND
RESULTS: Rat aortic smooth muscle cells were fixed and immunostained for versican and images of fluorescently labeled cells were obtained by confocal microscopy. Intracellular versican was detected in the nucleus and cytosol of vascular smooth muscle cells. The use of a synthetic neutralizing peptide eliminated versican immunostaining, demonstrating the specificity of the antibody used in this study. Western blot of pure nuclear extracts confirmed the presence of versican in the nucleus, and multifluorescent immunostaining showed strong colocalization of versican and nucleolin, suggesting a nucleolar localization of versican in nondividing cells. In dividing valve interstitial cells, a strong signal for versican was observed in and around the condensed chromosomes during the various stages of mitosis. Multifluorescent immunostaining for versican and tubulin revealed versican aggregated at opposing poles of the mitotic spindle during metaphase. Knockdown of versican expression using siRNA disrupted the organization of the mitotic spindle and led to the formation of multipolar spindles during metaphase.
CONCLUSIONS: Collectively, these data suggest an intracellular function for versican in vascular cells where it appears to play a role in mitotic spindle organization during cell division. These observations open a new avenue for studies of versican, suggesting even more diverse roles in vascular health and disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extracellular matrix; Nuleus; Proteoglycan; Smooth muscle cell; Valve interstitial cell; Vascular disease; Versican

Mesh:

Substances:

Year:  2015        PMID: 26395512     DOI: 10.1016/j.carpath.2015.07.010

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  7 in total

1.  A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro.

Authors:  Stephen P Evanko; Michel D Gooden; Inkyung Kang; Christina K Chan; Robert B Vernon; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2020-10-16       Impact factor: 2.479

Review 2.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

3.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.

Authors:  Sabrina Johanna Fletcher; Paula Alejandra Sacca; Mercedes Pistone-Creydt; Federico Andrés Coló; María Florencia Serra; Flavia Eliana Santino; Corina Verónica Sasso; Constanza Matilde Lopez-Fontana; Rubén Walter Carón; Juan Carlos Calvo; Virginia Pistone-Creydt
Journal:  J Exp Clin Cancer Res       Date:  2017-02-07

5.  Exosomes from hyperglycemia-stimulated vascular endothelial cells contain versican that regulate calcification/senescence in vascular smooth muscle cells.

Authors:  Shuang Li; Jun-Kun Zhan; Yan-Jiao Wang; Xiao Lin; Jia-Yu Zhong; Yi Wang; Pan Tan; Jie-Yu He; Xing-Jun Cui; Yi-Yin Chen; Wu Huang; You-Shuo Liu
Journal:  Cell Biosci       Date:  2019-01-03       Impact factor: 7.133

6.  Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.

Authors:  Natasha McRae; Leonard Forgan; Bryony McNeill; Alex Addinsall; Daniel McCulloch; Chris Van der Poel; Nicole Stupka
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

7.  Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles.

Authors:  Alex B Addinsall; Leonard G Forgan; Natasha L McRae; Rhys W Kelly; Penny L McDonald; Bryony McNeill; Daniel R McCulloch; Nicole Stupka
Journal:  Biomolecules       Date:  2020-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.